Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152357 | SCV000201276 | uncertain significance | not specified | 2014-07-01 | criteria provided, single submitter | clinical testing | The Arg10933His variant in TTN has not been previously reported in individuals w ith cardiomyopathy or in large population studies. Computational prediction tool s and conservation analysis do not provide strong support for or against an impa ct to the protein. In summary, the clinical significance of the Arg10933His vari ant is uncertain. |
Eurofins Ntd Llc |
RCV000725706 | SCV000338757 | uncertain significance | not provided | 2016-07-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001089127 | SCV001004242 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725706 | SCV001782422 | likely benign | not provided | 2019-06-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002381479 | SCV002692295 | likely benign | Cardiovascular phenotype | 2020-03-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000725706 | SCV004237458 | uncertain significance | not provided | 2023-08-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004734713 | SCV005344940 | likely benign | TTN-related disorder | 2024-06-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |